WHO Distributes Advanced Diagnostic Cameras to Syrdarya for Early Detection of Diabetic Retinopathy
The World Health Organization (WHO) and the World Diabetes Foundation have partnered with the Syrdarya Regional Health Department to combat the threat of diabetic retinopathy in Uzbekistan. This serious complication of type 2 diabetes affects the retina and can lead to severe vision impairment or blindness if left untreated.
As part of a pilot project, five advanced fundus cameras have been provided to healthcare facilities in Guliston, Sardoba, Oqoltin, and Boyovut districts. These cameras will enable healthcare providers to detect diabetic retinopathy early, allowing for timely intervention and treatment.
Routine screenings for diabetes-related retinal damage are not widely available in Uzbekistan, making this initiative all the more crucial in addressing vision issues related to diabetes. All patients with type 2 diabetes in the four pilot districts will undergo diabetic retinopathy screening, with those diagnosed being referred to specialized eye microsurgery centers for laser correction.
Managed by the WHO, the World Diabetes Foundation, and Uzbekistan’s Ministry of Health, this collaborative effort aims to improve diabetic care and prevent blindness due to diabetic retinopathy. According to Vision Atlas, over 3.3 million people in Uzbekistan suffer from visual impairment, with 94,000 individuals experiencing total blindness from various causes, including diabetic retinopathy.
This initiative marks a significant step forward in the fight against diabetes-related vision issues in Uzbekistan, showcasing the importance of early diagnosis and treatment in preserving eye health and preventing unnecessary blindness.
